BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2014-11-13
What BIORESTORATIVE THERAPIES, INC. reported in its quarterly report filed 2014-11-13 (fiscal Q3 2014): 27 published measures, 73 facts as tagged in accession 0001144204-14-067818.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-11-13
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001144204-14-067818 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 1,596,176 | USD | |
| At 2013-12-31 | 1,382,915 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 8,054,301 | USD | |
| At 2013-12-31 | 8,067,984 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | -6,458,125 | USD | |
| At 2013-12-31 | -6,685,069 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -1,100,454 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -4,103,269 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -1,303,008 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -4,120,201 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 1,526 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 159,930 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 336,246 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 125 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,680 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 73,575 | USD | |
| At 2013-12-31 | 35,568 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 1,075,499 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 582,061 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -896,007 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -3,605,912 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -1,129,002 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -3,542,461 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 421,515 | USD | |
| At 2013-12-31 | 239,802 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 74,780 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 220,301 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 56,036 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 285,939 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 7,427,661 | USD | |
| At 2013-12-31 | 7,502,550 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 774,054 | USD | |
| At 2013-12-31 | 1,269,970 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 989,822 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 3,833,617 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,129,117 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 3,543,933 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 17,385 | USD | |
| At 2013-12-31 | 17,965 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 93,815 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 227,705 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 115 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,472 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 290,707 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,077,778 | USD | 273 |
| 2014-07-13 to 2014-07-15 | 89,063 | USD | 3 |
| 2013-07-01 to 2013-09-30 | 414,918 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,188,276 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 31,018,928 | shares | |
| At 2013-12-31 | 19,074,552 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 17,457,980 | USD | |
| At 2013-12-31 | 13,139,712 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 1,055,186 | USD | |
| At 2013-12-31 | 1,107,545 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 1,220,282 | USD | |
| At 2013-12-31 | 1,176,662 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 30,160 | USD | |
| At 2013-12-31 | 20,739 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 502,783 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,687,415 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 513,909 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,719,270 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 73,889 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 79,064 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -204,447 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -497,357 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -174,006 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -577,740 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -580 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 5,481 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -488,416 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 384,843 | USD | 273 |
Inspect the source
- Entity
- BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
- Captured
- 2026-09-19T11:18:28.483Z
- SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))